Edinburgh-based Voxar announced a four-fold increase in annual U.S. sales to $1 million, and says it is planning to go public within the next year.Voxar's Plug 'n View 3D, which allows rapid display of 3-D CT, MRI, and other images on standard PC
Edinburgh-based Voxar announced a four-fold increase in annual U.S. sales to $1 million, and says it is planning to go public within the next year.
Voxar's Plug 'n View 3D, which allows rapid display of 3-D CT, MRI, and other images on standard PC hardware, has shown marketing success in Europe and Japan as well, according to a company spokesperson.
The firm recently announced new funding of $7.2 million and said it plans to relocate to larger quarters and double its number of employees to 150 within the next year.
Investors have agreed to increase employee equity in Voxar from 10% to 15%, which will "provide a significant boost to our recruitment program," according to a statement by CEO Andrew Bissell.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.